Literature DB >> 9047077

Nitric oxide attenuates adhesion molecule expression in human endothelial cells.

M Takahashi1, U Ikeda, J Masuyama, H Funayama, S Kano, K Shimada.   

Abstract

Leukocyte adhesion to vascular endothelium is a crucial step in the early stages of atherosclerosis, which may be mediated by the interaction of adhesion molecules expressed on the surfaces of both cell types. In this study, we investigated the effects of nitric oxide (NO) on the expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in human umbilical vein endothelial cells (HUVECs). ICAM-1 and VCAM-1 protein and mRNA expression were determined by cellular ELISA and Northern blot analysis, respectively. Both ICAM-1 and VCAM-1 expression were increased markedly by interleukin-1 beta (IL-1 beta). This IL-1 beta-mediated induction of ICAM-1 and VCAM-1 expression was significantly inhibited in the presence of a NO donor 3-morpholino-sydnonimine (SIN-1) in a dose-dependent manner. The inhibitory effect of SIN-1 was abolished in the presence of a NO scavenger haemoglobin, while addition of 8-bromo-cGMP showed no significant effect on IL-1 beta-induced ICAM-1 or VCAM-1 expression. Northern blot analysis showed that IL-1 beta markedly increased ICAM-1 and VCAM-1 mRNA expression, while SIN-1 decreased the accumulation of these transcripts induced by IL-1 beta. These results suggest that NO could prevent the focal adhesion and accumulation of leukocytes through the inhibition of ICAM-1 and VCAM-1 expression in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9047077     DOI: 10.1006/cyto.1996.0109

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  18 in total

Review 1.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

Review 2.  Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Authors:  John Greenwood; Lawrence Steinman; Scott S Zamvil
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

3.  Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality.

Authors:  Gregory J Kato; Sabrina Martyr; William C Blackwelder; James S Nichols; Wynona A Coles; Lori A Hunter; Marie-Luise Brennan; Stanley L Hazen; Mark T Gladwin
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

4.  Inorganic nitrate supplementation enhances functional capacity and lower-limb microvascular reactivity in patients with peripheral artery disease.

Authors:  Joshua M Bock; David P Treichler; Samuel L Norton; Kenichi Ueda; William E Hughes; Darren P Casey
Journal:  Nitric Oxide       Date:  2018-08-15       Impact factor: 4.427

5.  The Endothelial Nitric Oxide Synthase (NOS3-786T>C) Genetic Polymorphism in Chronic Heart Failure: Effects of Mutant -786C allele on Long-term Mortality.

Authors:  Sait Terzi; Ayşe Emre; Kemal Yesilcimen; Selçuk Yazıcı; Aysun Erdem; Ufuk Sadik Ceylan; Figen Ciloglu
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

6.  Severe sickle cell anemia is associated with increased plasma levels of TNF-R1 and VCAM-1.

Authors:  Daniel A Dworkis; Elizabeth S Klings; Nadia Solovieff; Guihua Li; Jacqueline N Milton; Stephen W Hartley; Efthymia Melista; Jason Parente; Paola Sebastiani; Martin H Steinberg; Clinton T Baldwin
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

7.  Regulation of ICAM-1 expression in mouse macrophages.

Authors:  A K Hubbard; C Giardina
Journal:  Inflammation       Date:  2000-04       Impact factor: 4.092

8.  Association of soluble cell adhesion molecules with ankle-brachial index in a biethnic cohort of predominantly hypertensive individuals.

Authors:  Mahyar Khaleghi; Zeenat Ali; Thomas H Mosley; Stephen T Turner; Iftikhar J Kullo
Journal:  Clin Chem       Date:  2008-09-11       Impact factor: 8.327

9.  Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes.

Authors:  Taoufik Khalfaoui; Gérard Lizard; Amel Ouertani-Meddeb
Journal:  J Mol Histol       Date:  2007-12-30       Impact factor: 2.611

10.  Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells.

Authors:  T Ishizuka; M Kawakami; T Hidaka; Y Matsuki; M Takamizawa; K Suzuki; A Kurita; H Nakamura
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.